Cargando…

Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia

BACKGROUND: The World Health Organization recommends that children should be informed of their HIV status at age 6–12 years. However, disclosure of HIV status among children is very low in resource-limited areas, particularly in Ethiopia. So, the aim of this study was to determine the prevalence of...

Descripción completa

Detalles Bibliográficos
Autores principales: Tucho, Walelign Atomsa, Tekelehaimanot, Aderajew Nigusse, Habte, Mahilet Berhanu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242142/
https://www.ncbi.nlm.nih.gov/pubmed/34211313
http://dx.doi.org/10.2147/PHMT.S314259
_version_ 1783715567405891584
author Tucho, Walelign Atomsa
Tekelehaimanot, Aderajew Nigusse
Habte, Mahilet Berhanu
author_facet Tucho, Walelign Atomsa
Tekelehaimanot, Aderajew Nigusse
Habte, Mahilet Berhanu
author_sort Tucho, Walelign Atomsa
collection PubMed
description BACKGROUND: The World Health Organization recommends that children should be informed of their HIV status at age 6–12 years. However, disclosure of HIV status among children is very low in resource-limited areas, particularly in Ethiopia. So, the aim of this study was to determine the prevalence of disclosure and associated factors among a cohort of HIV-infected children in southwest Ethiopia. METHODS: A facility-based cross-sectional study design was employed among caregivers of HIV-positive children aged 6–15 in Bench sheko and West Omo zone Southwest Ethiopia, from March 1 to April 20, 2020. Study participants were included using a consecutive sampling technique. Data were collected using a pretested interviewer administered questionnaire and checklist. A multivariable logistic regressions model was used to identify independent predictors of disclosure. The significance of association was declared by AOR at 95% confidence and a p-value <0.05. RESULTS: A total of 327 participants were involved in the study yielding a 95% response rate. The prevalence of HIV-positive status disclosure was 45.6% (95% CI=41.01–51.02). Caregiver secondary education and above (AOR=3.16, 95% CI=1.07–9.34), caregiver discussed about disclosure with health professionals (AOR= 9.56, 95% CI=4.88–18.74), child age 10–15 year old (AOR=3.64, 95% CI=1.64–8.08), duration on ART >5 years (AOR=5.08, 95% CI=1.57–16.37), treatment follow-up at hospital (AOR=2.23, 95% CI=1.27–5.01) and having treatment support for Children (AOR=3.84, 95% CI=1.88–7.85) were independent predictors of HIV-positive status disclosure. CONCLUSION: Disclosure of HIV status to children is low. Caregivers educational status, caregivers discussion with health professional, older child, duration on ART of more than 5 year, getting treatment service from hospital, and having a treatment support group are factors that enable disclosure. Therefore, concerted efforts based on the findings of this study will be required to improve the disclosure status among HIV-positive children.
format Online
Article
Text
id pubmed-8242142
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-82421422021-06-30 Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia Tucho, Walelign Atomsa Tekelehaimanot, Aderajew Nigusse Habte, Mahilet Berhanu Pediatric Health Med Ther Original Research BACKGROUND: The World Health Organization recommends that children should be informed of their HIV status at age 6–12 years. However, disclosure of HIV status among children is very low in resource-limited areas, particularly in Ethiopia. So, the aim of this study was to determine the prevalence of disclosure and associated factors among a cohort of HIV-infected children in southwest Ethiopia. METHODS: A facility-based cross-sectional study design was employed among caregivers of HIV-positive children aged 6–15 in Bench sheko and West Omo zone Southwest Ethiopia, from March 1 to April 20, 2020. Study participants were included using a consecutive sampling technique. Data were collected using a pretested interviewer administered questionnaire and checklist. A multivariable logistic regressions model was used to identify independent predictors of disclosure. The significance of association was declared by AOR at 95% confidence and a p-value <0.05. RESULTS: A total of 327 participants were involved in the study yielding a 95% response rate. The prevalence of HIV-positive status disclosure was 45.6% (95% CI=41.01–51.02). Caregiver secondary education and above (AOR=3.16, 95% CI=1.07–9.34), caregiver discussed about disclosure with health professionals (AOR= 9.56, 95% CI=4.88–18.74), child age 10–15 year old (AOR=3.64, 95% CI=1.64–8.08), duration on ART >5 years (AOR=5.08, 95% CI=1.57–16.37), treatment follow-up at hospital (AOR=2.23, 95% CI=1.27–5.01) and having treatment support for Children (AOR=3.84, 95% CI=1.88–7.85) were independent predictors of HIV-positive status disclosure. CONCLUSION: Disclosure of HIV status to children is low. Caregivers educational status, caregivers discussion with health professional, older child, duration on ART of more than 5 year, getting treatment service from hospital, and having a treatment support group are factors that enable disclosure. Therefore, concerted efforts based on the findings of this study will be required to improve the disclosure status among HIV-positive children. Dove 2021-06-25 /pmc/articles/PMC8242142/ /pubmed/34211313 http://dx.doi.org/10.2147/PHMT.S314259 Text en © 2021 Tucho et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tucho, Walelign Atomsa
Tekelehaimanot, Aderajew Nigusse
Habte, Mahilet Berhanu
Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia
title Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia
title_full Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia
title_fullStr Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia
title_full_unstemmed Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia
title_short Disclosure Status and Associated Factors Among Children on Antiretroviral Therapy in Ethiopia
title_sort disclosure status and associated factors among children on antiretroviral therapy in ethiopia
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8242142/
https://www.ncbi.nlm.nih.gov/pubmed/34211313
http://dx.doi.org/10.2147/PHMT.S314259
work_keys_str_mv AT tuchowalelignatomsa disclosurestatusandassociatedfactorsamongchildrenonantiretroviraltherapyinethiopia
AT tekelehaimanotaderajewnigusse disclosurestatusandassociatedfactorsamongchildrenonantiretroviraltherapyinethiopia
AT habtemahiletberhanu disclosurestatusandassociatedfactorsamongchildrenonantiretroviraltherapyinethiopia